Natasha Hass, LMFT in Biscayne Park, FL - Marriage & Family Therapist

Natasha Hass, LMFT is a Marriage & Family Therapist based in Biscayne Park, Florida. Natasha Hass is licensed to practice in Florida (license number 4107) and her current practice location is 10907 Ne 9th Ave, Biscayne Park, Florida. She can be reached at her office (for appointments etc.) via phone at (305) 345-3385.

NPI number for Natasha Hass is 1285206334 and her current mailing address is 10907 Ne 9th Ave, Biscayne Park, Florida. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1285206334.

Contact Information

	Natasha Hass, LMFT
	10907 Ne 9th Ave, Biscayne Park, FL 33161-7225
	(305) 345-3385
	Not Available

Healthcare Provider's Profile

Full Name	Natasha Hass
Gender	Female
Speciality	Marriage & Family Therapist
Location	10907 Ne 9th Ave, Biscayne Park, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1285206334
Provider Enumeration Date: 07/16/2021
Last Update Date: 07/16/2021

Medical Identifiers

Medical identifiers for Natasha Hass such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285206334	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	4107 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Natasha Hass is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Natasha Hass, LMFT 10907 Ne 9th Ave, Biscayne Park, FL 33161-7225 Ph: (305) 345-3385	Natasha Hass, LMFT 10907 Ne 9th Ave, Biscayne Park, FL 33161-7225 Ph: (305) 345-3385

News Archive

New drug could prevent Alzheimer's by modulating key enzyme involved in amyloid plaque formation

Amyloid plaques are pathological hallmarks of Alzheimer's disease (AD) - clumps of misfolded proteins that accumulate in the brain, disrupting and killing neurons and resulting in the progressive cognitive impairment that is characteristic of the widespread neurological disorder.

Biomoda submits new U.S. Patent application for CyPath lung cancer assay

Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.

Exelixis grants 25,200 shares to nine new employees

Exelixis, Inc. announced that today it granted restricted stock units representing an aggregate of 25,200 shares of Exelixis common stock to nine new employees.

UH researchers report new gut–liver drug recycling process

A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.

Researchers identify genetic cause of a rare neurological disorder

In a paper published today in Nature Communications, an international group of collaborators led by researchers at UPMC Children's Hospital of Pittsburgh have identified a genetic cause of a rare neurological disorder marked by developmental delay and loss of coordination, or ataxia.

Natasha Hass, LMFT - Couples Therapy in Biscayne Park, FL